BBVA
AQST icon

Banco Bilbao Vizcaya Argentaria’s Aquestive Therapeutics AQST Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-40,512
Closed -$196K – 682
2020
Q2 		$196K Hold
40,512
– – 0.01% 716
2020
Q1 		$88K Buy
40,512
+10,512
+35% +$39.9K ﹤0.01% 654
2019
Q4 		$174K Buy
+30,000
New +$156K 0.01% 688

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's AQST Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Aquestive Therapeutics (AQST) in Q3 2020, closing a stake of 40,512 shares — an estimated $196K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in AQST in Q4 2019 and held it in 3 quarters. The position peaked at $196K in Q2 2020. 60 funds tracked by Wall St. Rank hold AQST as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Aquestive Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 40,512 Aquestive Therapeutics shares in Q3 2020, an estimated $196K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Aquestive Therapeutics in Q4 2019 and held it in 3 quarters.
  • Banco Bilbao Vizcaya Argentaria's Aquestive Therapeutics position peaked at $196K in Q2 2020.
  • 60 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.